Author

G. Guillen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Martin· 2 shared A. Manzano-Munoz· 1 shared A. Musacchio· 1 shared A. Soriano· 1 shared A. Villanueva· 1 shared B. Perez-Masson· 1 shared C. Alcon· 1 shared C. Canaan-Haden· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. Martin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The Nucleocapsid Protein Of SARS-CoV-2, Combined With ODN-39M, Is A Potential Component For An Intranasal Bivalent Pancorona Vaccine

Y. Lobaina, R. Chen, E. Suzarte, P. Ai, V. Huerta, A. Musacchio, R. Silva, C. Tan, A. Martin, L. Lazo, G. Guillen, K. Yang, Y. Perera, L. Hermida

This paper evaluates a bivalent intranasal vaccine candidate combining SARS-CoV-2 N protein and ODN-39M, showing cross-reactive immunity against SARS-CoV-1 and enhanced Th1 response when combined with RBD.

bioRxiv · Jun 2, 2022 · PreprintImmunology

In-solution buffer-free digestion for the analysis of SARS-CoV-2 RBD proteins allows a full sequence coverage and detection of post-translational modifications in a single ESI-MS spectrum

L. A. Espinosa, Y. Ramos, I. Andujar, E. O. Torres, G. Cabrera, A. Martin, D. Gonzalez, G. Chinea, M. Becquet, I. Gonzalez, C. Canaan-Haden, E. Nelson, G. Rojas, B. Perez-Masson, D. Perez-Martinez, , L. J. Gonzalez

This paper introduces an in-solution buffer-free digestion method for analyzing SARS-CoV-2 RBD proteins, achieving full sequence coverage and detecting post-translational modifications in a single ESI-MS spectrum.

bioRxiv · May 10, 2021 · PreprintBiochemistry

Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistance.

C. Alcon, A. Manzano-Munoz, E. Prada, J. Mora, A. Soriano, G. Guillen, S. Gallego, J. Roma, J. Samitier, A. Villanueva, J. Montero

This study uses dynamic BH3 Profiling to identify BH3 mimetic combinations that enhance chemotherapy efficacy and prevent resistance in rhabdomyosarcoma.

bioRxiv · Jan 24, 2020Cancer Biology